Where does Akeso Biomedical, Inc. rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Akeso Biomedical, Inc. ranks #19,425 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Akeso Biomedical, Inc. hold?

Akeso Biomedical, Inc. holds 14 US utility patents granted between 2017 and 2022, spanning 15 technology areas.

What is Akeso Biomedical, Inc.'s Innovation Score?

Akeso Biomedical, Inc. has an Innovation Score of 31.9 out of 100 (39th percentile of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does Akeso Biomedical, Inc. focus on?

Akeso Biomedical, Inc.'s top technology area is A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations) with 14 patents, ranking #1,384 of 6,058 assignees active in that subclass. Grants appear in 15 CPC subclasses total.

Is Akeso Biomedical, Inc.'s patent grant rate increasing or decreasing?

Akeso Biomedical, Inc.'s recent grant velocity is -44% compared to the prior five-year period (grant years, not application filing dates). Grant activity has slowed relative to earlier years.

What does claim depth mean for Akeso Biomedical, Inc.'s patents?

Akeso Biomedical, Inc.'s patents average 13.6 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Akeso Biomedical, Inc. patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView US Corporation

Akeso Biomedical, Inc.

USPTO PatentsView assignee record - 14 granted patents across 15 technology areas, recorded in grant years 2017–2022. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Akeso ranks #19,425 of 49,997 tracked US assignees by granted-patent volume, with 14 patents across 15 technology areas.

#19,425
of 49,997 US assignees by volume: 39th percentile
by Innovation Score (31.9/100): 13.6
avg claims per patent: -44%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R19425 · US Corporation #19,425 · 14 grants

GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-FOCUS · INNOV-THIN · CLAIMS-RICH · TYPE-USCORP · VEL-DROP · BOOK-FULL

GRANTS-MICRO 14 grants
MID-PACK #19,425/49,997
PHOTO-FINISH AI Speech
CPC-FOCUS A61P · 15 areas
INNOV-THIN 31.9/100
CLAIMS-RICH 13.6 claims/avg
TYPE-USCORP US Corporation
VEL-DROP -44% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: AI Speech Co., Ltd. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Akeso’s 31.9 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 9.4 pts (29%) Velocity 0.7 pts (2%) Breadth 13.7 pts (43%) Claim depth 8.1 pts (25%)

Qualcomm Incorporated · highest

85
Akeso Biomedical · this assignee

32
3D Lighting… · lowest

7

What this shows Akeso's Innovation Score is 31.9/100 (39th percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Akeso?

Each dot is one of Akeso’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Akeso’s own 13.6 claims/patent is at or below the 14.1 median for these volume peers. Volume here does not track with deeper claims; several lower-volume peers claim more thoroughly per patent.

Akeso vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Akeso's grants concentrate

Akeso Biomedical, Inc. is a focused PatentsView assignee: 15 CPC subclasses with 100% of grants classified under A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations). Peak complete grant year is 2019 (5 grants) versus a trough of 1 in 2017. By volume, Akeso sits between AI Speech Co., Ltd. and Altaviz, LLC.

Akeso's three-year grant acceleration

Akeso Biomedical, Inc. shows 1 grants in 2022–2024 against only 9 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

AI Speech

14
AI Therapeutics

14
Airspace

14
Aito BV

14
ALE International

14
Allprofessional M…

14
Alorica Business…

14
Altaviz

14
Akeso Biomedical ◀

14

What this shows Akeso holds 14 patents at rank #19,409, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Akeso

By rank, the assignees closest to #19,409 in granted patent volume.

Leaders in A61P (Specific Therapeutic Activity OF Chemical Compounds OR Me…)

Other assignees with the most granted patents in Akeso's primary technology class.

Akeso's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

32 39th percentile higher than 39% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2017–2022

Grants by year

Teal-shaded recent years (2020–present) versus the 2017–2019 baseline. Full figures in the table below.

View data table

Akeso Biomedical, Inc. patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2017	1	7.1%
2018	3	21.4%
2019	5	35.7%
2020	4	28.6%
2022	1	7.1%

Which technologies does Akeso Biomedical, Inc. patent most?

A61P - Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations 14

A23K - Fodder 14

A61K - Preparations FOR Medical, Dental OR Toiletry Purposes 14

C09D - Coating Compositions, e.g. Paints, Varnishes OR LACQUERS; Filling PASTES; Chemical Paint OR INK REMOVERS; INKS; Correcting FLUIDS; WOODSTAINS; Pastes OR Solids FOR Colouring OR PRINTING; USE OF Materials Therefor 12

A01N - Preservation OF Bodies OF Humans OR Animals OR Plants OR Parts Thereof ; Biocides, e.g. AS Disinfectants, AS Pesticides OR AS Herbicides ; Pest Repellants OR ATTRACTANTS; Plant Growth Regulators 12

C07F - Acyclic, Carbocyclic OR Heterocyclic Compounds Containing Elements Other Than Carbon, Hydrogen, Halogen, Oxygen, Nitrogen, Sulfur, Selenium OR Tellurium 10

A23L - Foods, Foodstuffs OR Non-alcoholic Beverages, NOT Otherwise Provided FOR; Preparation OR Treatment Thereof 10

A23V - Indexing Scheme Relating TO Foods, Foodstuffs OR Non-alcoholic Beverages AND Lactic OR Propionic Acid Bacteria Used IN Foodstuffs OR Food Preparation 10

A61L - Methods OR Apparatus FOR Sterilising Materials OR Objects IN GENERAL; Disinfection, Sterilisation OR Deodorisation OF AIR; Chemical Aspects OF Bandages, Dressings, Absorbent Pads OR Surgical ARTICLES; Materials FOR Bandages, Dressings, Absorbent Pads OR Surgical Articles 9

Y02A - Technologies FOR Adaptation TO Climate Change 9

G02B - Optical Elements, Systems OR Apparatus 7

A22C - Processing Meat, Poultry, OR Fish 3

A61Q - Specific USE OF Cosmetics OR Similar Toiletry Preparations 3

A01K - Animal HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; Rearing OR Breeding Animals, NOT Otherwise Provided FOR; NEW Breeds OF Animals 3

C12Q - Measuring OR Testing Processes Involving Enzymes, Nucleic Acids OR Microorganisms ; Compositions OR Test Papers THEREFOR; Processes OF Preparing Such COMPOSITIONS; Condition-responsive Control IN Microbiological OR Enzymological Processes 2

Top 15 of 15 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Akeso Biomedical, Inc.'s patent record in context - here's where to go next.

Akeso Biomedical, Inc.'s lead technology class is A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations), 100% of its portfolio - see every assignee active in that class. Explore A61P
Ranked #19,425 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Akeso Biomedical, Inc. against AI Speech Co., Ltd., an assignee filing at a similar volume. Compare portfolios
Innovation Score of 31.9/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.